Eli Lilly takes its trial work on the road, literally, as it loads up RVs to broaden its study reach
Eli Lilly takes its trial work on the road, literally, [...]
Visus raises $20M ahead of data drop on rival to AbbVie prospect
Visus raises $20M ahead of data drop on rival to [...]
FDA finds fault with Axsome’s depression filing, sinking stock
FDA finds fault with Axsome’s depression filing, sinking stock ntaylor [...]
Pragmatism prevails for Dicerna as it looks to out-license the sales work for mixed bag nedosiran
Pragmatism prevails for Dicerna as it looks to out-license the [...]
Mixed pivotal data on Dicerna rival to Alnylam drug sink stock
Mixed pivotal data on Dicerna rival to Alnylam drug sink [...]
Dicerna’s stock sinks after its Alnylam rival shows mixed data, stymieing approval filing
Dicerna’s stock sinks after its Alnylam rival shows mixed data, [...]
Study of dogs and cats sheds light on key immune pathways
Study of dogs and cats sheds light on key immune [...]
Amgen pauses FLT3 bispecific trial, resumes dosing in BCMA study
Amgen pauses FLT3 bispecific trial, resumes dosing in BCMA study [...]
Pitt’s inhalable anti-COVID nanobodies, inspired by llamas, ‘remarkably active’ against delta variant: study
Pitt’s inhalable anti-COVID nanobodies, inspired by llamas, ‘remarkably active’ against [...]
Sage Therapeutics axes 2 zuranolone trials deemed unnecessary for approval in depression
Sage Therapeutics axes 2 zuranolone trials deemed unnecessary for approval [...]